Sanofi-Aventis Fights Off Plavix Patent Challenge In Canada

Law360, New York (March 22, 2005, 12:00 AM EST) -- French drug maker Sanofi-Aventis SA has won a Canadian lawsuit to stop Apotex Inc. from launching a generic version of its top-selling drug, the blood thinner Plavix.

Canada's Federal Court issued the ruling late Monday, rejecting Apotex's challenge to the Plavix patent and holding that the asserted claims are novel, not obvious and infringed.

Apotex said it planned to appeal the case.

The decision, after a trial that ran from Feb. 21 to Feb. 25, came earlier than expected, about a month ahead of the April...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.